Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes

Fred M Wu1, Maureen M Jonas2, Alexander R Opotowsky1

  • 1Department of Cardiology, Boston Children's Hospital, Harvard Medical School; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School.

Insights

Individuals with Fontan physiology have a high prevalence of hepatic fibrosis, with nearly all showing centrilobular fibrosis and over 80% exhibiting portal fibrosis. Liver disease signs did not predict these findings, and advanced disease risk factors were few.

Area of Science:

  • Cardiology
  • Hepatology
  • Pediatric Surgery

Background:

  • The Fontan operation is a palliative surgical procedure for single ventricle congenital heart disease.
  • Congestive hepatopathy and cirrhosis are known complications, but prevalence and predictors of liver disease are unclear.

Purpose of the Study:

  • To investigate the prevalence and characteristics of liver disease in individuals with Fontan circulation.
  • To identify predictors of liver histopathology and their impact on survival.

Main Methods:

  • Retrospective study of liver histopathology from 68 Fontan subjects via biopsy or autopsy.
  • Grading of liver specimens and chart review for clinical data.
  • Analysis of histopathology findings in relation to clinical factors and survival.

Main Results:

  • All specimens showed centrilobular fibrosis (41.2% Grade 4); 82.3% had portal fibrosis (14.7% cirrhosis).
  • Megamitochondria observed in 58.8% of specimens.
  • Higher fibrosis grades in dominant ventricle types; portal fibrosis correlated with alkaline phosphatase and biopsy mode. No correlation with survival.

Conclusions:

  • Fontan physiology is associated with a high prevalence of hepatic fibrosis.
  • Clinical signs of liver disease did not correlate with histopathology.
  • Few risk factors for advanced liver disease were identified, and histopathology did not predict survival.
Abstract